Cryo-electron microscopy (Cryo-EM) and drug design
Our research program is focused on exploring frontiers in structural biology and drug design using cryo electron microscopy (cryo-EM), with the central goal of accelerating the development of effective therapeutic agents. The program is guided by two overarching themes:
Drug Design

A highly focused team effort to use high-resolution cryo-EM imaging of native protein complexes to design effective therapeutic agents targeting cancer, infectious diseases and brain disorders.
Technology Development

An interdisciplinary approach towards developing next generation technologies in cryo-EM using state-of-the-art AI tools and automated workflows coupled with advanced image processing and machine learning.
News
-
To pandemic preparedness and beyond: Accelerating novel antibody therapeutics through cross-border collaboration
Innovation UBC | October 14, 2025 Through this new collaboration, Alloy will share its expertise and drug discovery technologies to support UBC’s efforts to develop antibody therapies for infectious disease targets. Working directly with UBC’s Pathogen Response Optimization by GENeratIng ThErapeutics Rationally (PROGENITER) program led by Dr. Sriram Subramaniam, Professor and Gobind Khorana Canada Excellence…
-
Delivering AI’s promise of better health care
The University of British Columbia Faculty of Medicine News | June 12, 2025 Jump-started by a $22.5 million gift, UBC’s new AI and Health Network is deploying powerful artificial intelligence tools to drive health system innovation and improve patient care. One project, led by UBC professor Dr. Sriram Subramaniam, is combining AI with advanced cryo-electron…
-
$140M for UBC-led research hub to accelerate drug development and biomanufacturing
The University of British Columbia Faculty of Medicine News | June 4, 2024 The funding supports four multidisciplinary research projects through Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH), a UBC-led alliance of more than 50 academic, industry, not-for-profit and health system partners that have come together to make Canada a leader in advanced immune-based therapeutics like RNA vaccines,…








